Hikma Pharmaceuticals PLC (HIK) — Net Asset Momentum
Hikma Pharmaceuticals PLC (HIK) recorded a net asset momentum of 5.1% as of December 2024, with net assets of GBX2.32 Billion GBX. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. See Hikma Pharmaceuticals PLC defensive interval ratio to measure how many days the company can operate on defensive assets alone.
YoY Momentum
Current Net Assets
Years of Data
Country
Hikma Pharmaceuticals PLC Net Asset Momentum (2002–2024)
This chart tracks Hikma Pharmaceuticals PLC's year-over-year net asset growth across 23 annual reporting periods from 2002 to 2024. The most recent momentum reading is +5.1%, with net assets of GBX2.32 Billion GBX as of December 2024. Read total liabilities of Hikma Pharmaceuticals PLC for a breakdown of total debt and financial obligations.
Annual Net Asset History for Hikma Pharmaceuticals PLC (2002–2024)
The table below shows the complete annual net asset history for Hikma Pharmaceuticals PLC from 2002 to 2024, covering 23 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see HIK market cap overview.
| Year | Net Assets (GBX) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2024 | GBX2.32 Billion | GBX5.13 Billion | GBX2.81 Billion | ▲ +5.1% |
| 2023 | GBX2.21 Billion | GBX4.68 Billion | GBX2.47 Billion | ▲ +2.8% |
| 2022 | GBX2.15 Billion | GBX4.47 Billion | GBX2.32 Billion | ▼ -12.9% |
| 2021 | GBX2.47 Billion | GBX4.37 Billion | GBX1.91 Billion | ▲ +14.9% |
| 2020 | GBX2.15 Billion | GBX4.13 Billion | GBX1.99 Billion | ▲ +0.9% |
| 2019 | GBX2.13 Billion | GBX3.93 Billion | GBX1.80 Billion | ▲ +25.5% |
| 2018 | GBX1.70 Billion | GBX3.50 Billion | GBX1.80 Billion | ▲ +11.1% |
| 2017 | GBX1.53 Billion | GBX3.39 Billion | GBX1.86 Billion | ▼ -36.6% |
| 2016 | GBX2.41 Billion | GBX4.36 Billion | GBX1.95 Billion | ▲ +78.3% |
| 2015 | GBX1.35 Billion | GBX2.60 Billion | GBX1.25 Billion | ▲ +11.2% |
| 2014 | GBX1.22 Billion | GBX2.25 Billion | GBX1.03 Billion | ▲ +17.6% |
| 2013 | GBX1.03 Billion | GBX1.93 Billion | GBX895.00 Million | ▲ +22.0% |
| 2012 | GBX847.85 Million | GBX1.73 Billion | GBX882.26 Million | ▲ +6.2% |
| 2011 | GBX798.63 Million | GBX1.58 Billion | GBX777.01 Million | ▲ +6.4% |
| 2010 | GBX750.30 Million | GBX1.12 Billion | GBX365.52 Million | ▲ +9.8% |
| 2009 | GBX683.26 Million | GBX1.02 Billion | GBX339.46 Million | ▲ +12.2% |
| 2008 | GBX609.00 Million | GBX966.46 Million | GBX357.46 Million | ▲ +43.4% |
| 2007 | GBX424.66 Million | GBX894.04 Million | GBX469.38 Million | ▲ +21.4% |
| 2006 | GBX349.80 Million | GBX488.36 Million | GBX138.56 Million | ▲ +21.7% |
| 2005 | GBX287.48 Million | GBX397.96 Million | GBX110.48 Million | ▲ +98.0% |
| 2004 | GBX145.18 Million | GBX246.48 Million | GBX101.31 Million | ▲ +140.1% |
| 2003 | GBX60.47 Million | GBX117.86 Million | GBX57.39 Million | ▲ +25.9% |
| 2002 | GBX48.03 Million | GBX94.86 Million | GBX46.84 Million | — |